非编码RNA在ALS中的作用
Alessandra Falduti1,2, Adele Giovinazzo2, Elisa Lo Feudo1,2
1Department of Experimental and Clinical Medicine, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Genes
|June 26, 2025
概括
非编码RNAs,如microRNAs (miRNAs),长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs),都与肌缩侧面硬化症 (ALS) 的发病有关. 它们的失调提供了作为ALS生物标志物和治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肌缩侧面硬化 (ALS) 是一种进展性神经退行性疾病,影响运动神经元,导致和死亡.
- 虽然遗传和环境因素有所贡献,但ALS发病的确切原因仍然未知.
- 非编码RNAs (ncRNAs) 越来越多地被认为是它们在疾病发病过程中的作用.
研究的目的:
- 审查非编码RNAs在肌缩侧面硬化症 (ALS) 的失调.
- 突出miRNAs,lncRNAs和circRNAs作为ALS生物标志物和治疗点的潜力.
主要方法:
- 文献综述侧重于非编码RNA在ALS中的作用.
- 对miRNAs,lncRNAs和circRNAs在ALS病变发生过程中所涉及的新兴证据的分析.
主要成果:
- 非编码RNA的异常表达与关键的ALS过程有关,如运动神经元存活,蛋白质聚合和炎症.
- 失调的非编码RNA涉及到ALS的零星和家族形式.
结论:
- 非编码RNA在ALS的致病机制中起着重要的作用.
- miRNAs,lncRNAs和circRNAs代表了ALS生物标志物开发和治疗策略的有希望的途径.
相关概念视频
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Types of RNA
6.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.5K
RNA Splicing
57.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.2K
Alternative RNA Splicing
21.8K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.8K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


